Autres langues Zentalis Pharmaceuticals, Inc.

Actions

ZNTL

US98943L1070

Recherche biotechnologique et médicale

Marché Fermé - Nasdaq 22:00:00 29/09/2026			Varia. 5j.	Varia. 1 janv.
2,715 ^USD	+4,42%		-11,85%	+101,11%

16/09	Zentalis Pharmaceuticals, Inc. : William Blair & Co. reste à l'achat	ZM
14/09	Transcript : Zentalis Pharmaceuticals, Inc. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-14-2026 02:35 PM

Autres langues

21/09	Zentalis Pharmaceuticals, Inc.(NasdaqGM:ZNTL) added to S&P Global BMI Index
02/09	Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences
01/09	Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
20/08	Zentalis Pharmaceuticals Insider Bought Shares Worth $15,172,500, According to a Recent SEC Filing
18/08	Zentalis Pharmaceuticals Announces Closing of Underwritten Public Offering, Including Full Exercise of Underwriters' Option to Purchase Additional Shares
17/08	Zentalis Pharmaceuticals Closes Offering of Common Shares
17/08	Zentalis Pharmaceuticals Announces Closing of Underwritten Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
17/08	Zentalis Pharmaceuticals Announces Pricing of Underwritten Public Offering - August 13, 2026
14/08	Zentalis Pharmaceuticals Shares Fall After Pricing $80.5 Million Offering to Fund Clinical Pipeline
14/08	Zentalis Pharmaceuticals Prices $80.5 Million Offering to Fund Clinical Pipeline
14/08	Zentalis Pharmaceuticals Announces Pricing of Underwritten Public Offering
13/08	Zentalis Pharmaceuticals Announces Proposed Underwritten Public Offering
07/08	Zentalis Pharmaceuticals : Quarterly Report for Quarter Ending June 30, 2026 (Form 10-Q)
06/08	Zentalis Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
06/08	Zentalis Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Updates
03/08	Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
20/07	Zentalis Pharmaceuticals to Present at the European Society for Medical Oncology (ESMO) Congress 2026
17/07	Zentalis Pharmaceuticals to Present at the European Society for Medical Oncology (ESMO) Congress 2026
17/07	Zentalis Shares Rise After Mizuho Initiates Coverage at Outperform
29/06	Zentalis Pharmaceuticals, Inc.(NasdaqGM:ZNTL) added to Russell 2000 Index
29/06	Zentalis Pharmaceuticals, Inc.(NasdaqGM:ZNTL) added to Russell 2000 Value Benchmark
29/06	Zentalis Pharmaceuticals, Inc.(NasdaqGM:ZNTL) added to Russell 3000E Index
29/06	Zentalis Pharmaceuticals, Inc.(NasdaqGM:ZNTL) added to Russell 3000E Value Benchmark
29/06	Zentalis Pharmaceuticals, Inc.(NasdaqGM:ZNTL) added to Russell 3000 Value Benchmark
29/06	Zentalis Pharmaceuticals, Inc.(NasdaqGM:ZNTL) added to Russell 2000 Dynamic Index